The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma


Journal article


Achim Rothe*, Ron D. Jachimowicz*, Sven Borchmann*, Marie Madlener, Jörg Keßler, Katrin S. Reiners, Maike Sauer, Hinrich P. Hansen, Roland T. Ullrich, Sampurna Chatterjee, Peter Borchmann, Paul Yazaki, Thomas C. Koslowsky, Andreas Engert, Lukas C. Heukamp, Michael Hallek, Elke Pogge Von Strandmann, *contributed equally
International Journal of Cancer, vol. 134(12), 2014 May 15, pp. 2829-2840

Cite

APA
Rothe*, A., Jachimowicz*, R. D., Borchmann*, S., Madlener, M., Keßler, J., Reiners, K. S., … *contributed equally. (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. International Journal of Cancer, 134(12), 2829–2840.

Chicago/Turabian
Rothe*, Achim, Ron D. Jachimowicz*, Sven Borchmann*, Marie Madlener, Jörg Keßler, Katrin S. Reiners, Maike Sauer, et al. “The Bispecific Immunoligand ULBP2-ACEA Redirects Natural Killer Cells to Tumor Cells and Reveals Potent Anti-Tumor Activity against Colon Carcinoma.” International Journal of Cancer 134, no. 12 (May 15, 2014): 2829–2840.

MLA
Rothe*, Achim, et al. “The Bispecific Immunoligand ULBP2-ACEA Redirects Natural Killer Cells to Tumor Cells and Reveals Potent Anti-Tumor Activity against Colon Carcinoma.” International Journal of Cancer, vol. 134, no. 12, May 2014, pp. 2829–40.